ALPINE IMMUNE SCIENCES, INC. Cash and Cash Equivalents
ALPINE IMMUNE SCIENCES, INC. had Cash and Cash Equivalents of $33.02 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-05-09
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $33.02M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $43.92M.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $18.98M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $34.08M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2024-03-31 | $33.02M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $43.92M 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $18.98M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $34.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $14.46M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.38M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $126.63M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $24.36M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $34.89M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $67.91M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $76.10M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $18.81M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $12.63M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $34.96M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $141.07M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $88.22M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $24.45M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $16.12M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $17.39M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $15.47M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $41.44M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.71M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $11.47M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.57M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.45M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $8.00M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $11.98M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $27.55M 10-Q · filed 2017-07-21 | |
| 2017-03-31 | $12.93M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $11.82M 10-K · filed 2018-03-28 | $24.20M 10-K · filed 2017-02-13 |
| 2016-09-30 | $16.17M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $15.42M 10-Q · filed 2017-07-21 | |
| 2016-03-31 | $16.03M 10-Q · filed 2017-05-02 | |
| 2015-12-31 | $24.99M 10-Q · filed 2017-07-21 | |
| 2015-09-30 | $57.55M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $100.52M 10-Q · filed 2016-08-02 | |
| 2015-03-31 | $22.86M 10-Q · filed 2016-05-03 | |
| 2014-12-31 | $27.81M 10-K · filed 2017-02-13 | |
| 2014-09-30 | $1.09M 10-Q · filed 2015-11-03 | |
| 2014-06-30 | $121.00K 10-Q · filed 2015-08-04 | |
| 2013-12-31 | $1.10M 10-K · filed 2017-02-13 | |
| 2012-12-31 | $4.71M 10-K · filed 2016-03-08 |